Filing Details
- Accession Number:
- 0001104659-22-085629
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-03 16:11:37
- Reporting Period:
- 2022-08-01
- Accepted Time:
- 2022-08-03 16:11:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1657312 | Verona Pharma Plc | VRNA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1836883 | A. Kathleen Rickard | 3 More London Riverside London X0 SE1 2RE | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2022-08-01 | 56,432 | $0.67 | 2,404,792 | No | 4 | F | Direct | |
| Ordinary Shares | Disposition | 2022-08-02 | 28,752 | $0.70 | 2,376,040 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units.
- The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on July 29, 2022 divided by eight (8).
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
- The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $0.6913 to $0.7225. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.
- Consists of (i) 1,533,576 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 191,697 ADSs); and (ii) 842,464 Ordinary Shares underlying 105,308 ADSs.
Billionaire Hedge Funds
